MissionIR Articles
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Unveil Adaptive Design for Berubicin Phase 2 Clinical Trial in Nov. 12 Webinar
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced its plans to issue a video update…
-
Predictive Oncology (NASDAQ: POAI) Subsidiary’s HSC Technology Optimization Solution Offers Unparalleled Results, Benefits
POAI subsidiary Soluble Biotech’s optimization solution shaves time and cost off of traditional options offered by competition Results garnered from company’s HSC optimization are unparalleled in field Soluble Biotech lands first major contract, signifying major…
-
Acquisition Strategy Paying Off for Sustainable Green Team, Ltd. (SGTM) Through Increased Profits, International Expansion
National Storm Recovery Inc. acquired Mulch Manufacturing Inc. several months ago to create SGTM SGTM diverts storm waste from landfills to create attractive next-generation products that benefit the environment Mulch Manufacturing recently secured many new…
-
MissionIRNewsBreaks – CYBIN Inc. Completes Reverse Takeover Transaction
CYBIN (formerly Clarmin Explorations Inc.), a life sciences company initially focused on psychedelic pharmaceutical therapies, on Thursday announced it has completed its previously disclosed reverse takeover of Clarmin Explorations Inc. per the terms of an…
-
Knightscope, Inc. Is ‘One to Watch’
Knightscope is a leader in the development of autonomous security capabilities and is on target to disrupt the $500 billion security industry The company is presently in the process of raising up to $25 million…
-
VistaGen Therapeutics’ (NASDAQ: VTGN) New Generation Phase 3 Drug Candidate for Social Anxiety Disorder Gains Importance Amid FDA Wariness of Benzodiazepines
VistaGen has three innovative CNS drug candidates which target a wide range of anxiety, depression and neurological disorders PH94B, the Company’s most advanced drug candidate, is entering Phase 3 development for acute, on-demand treatment of…
-
SRAX Inc.’s (NASDAQ: SRAX) Sequire Delivers Valuable Insights into Consumer Behaviors, Aids Publicly Traded Companies in Investor Growth
Since its launch in early 2019, Sequire has gained 1 million active investors, traders from 91 public companies New name — Sequire — represents platform’s main objective to acquire, secure investors for publicly traded companies…
-
MissionIRNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Board Appointment of Dr. Khalid Islam
Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve survival and/or quality of life for patients with a high unmet medical need, today announced the appointment of Dr. Khalid Islam to its…
-
MissionIRNewsBreaks – The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Announces Its Alkaline88 Product Reaches No. 1 Spot at KeHE Winter Show
The Alkaline Water Company’s (NASDAQ: WTER) (CSE: WTER) flagship brand, Alkaline88(r), was the No. 1 item by cases sold at the recent KeHE Virtual Winter Show. The company produces premium bottled alkaline water, flavor-infused waters and…
-
MissionIRNewsBreaks– DarioHealth Corp. (NASDAQ: DRIO) to Report Q3 2020 Financial Results, Host Conference Call
DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, today announced that it will release financial results for its second quarter ended September 30, 2020, on Thursday, Nov. 12, 2020, as well as…
-
MissionIRNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Reschedules Webcast for Nov. 4, 2020
Energy Fuels (NYSE American: UUUU) (TSX: EFR) on Tuesday announced that, due to technical issues, its conference call and webcast originally scheduled for Nov. 3, 2020, has been postponed to be held at 4:00 pm…
-
MissionIRNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Featured in Research Report
Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve survival and/or quality of life for patients with high unmet medical need conditions, was featured in an institutional research report by Craig-Hallum Capital…
-
MissionIRNewsBreaks – VistaGen Therapeutics (NASDAQ: VTGN) Featured in Stock2Me Podcast
VistaGen (NASDAQ: VTGN), a biopharmaceutical company developing new generation medicines for anxiety, depression and other central nervous system (“CNS”) disorders, was featured in the latest episode of The Stock2Me Podcast, an InvestorBrandNetwork (“IBN”) solution to…
-
Sustainable Green Team Ltd. (SGTM) Subsidiary — Mulch Manufacturing — Awarded String of Contracts
Mulch Manufacturing has signed mulch supplier contract with Vero Beach, Florida This — and other recent contracts — made possible due to SGTM’s recent completion of construction on its Florida Waste Management facility Sustainable Green…
-
MissionIRNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Host Call, Live Webcast to Discuss Q3 2020 Results, Clinical Pipeline
Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve survival and/or quality of life for patients with high unmet medical need conditions, today announced that it will host a conference call and…
-
MissionIRNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Achieves Major Milestone in US REE Production
Energy Fuels (NYSE American: UUUU) (TSX: EFR) today announced that the company has produced a rare earth element (“REE”) carbonate concentrate (“REE Concentrate”) on a pilot scale at its 100% owned White Mesa Mill (the…
-
MissionIRNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Announces Filing Date for Second-Quarter Financial Report
Canopy Rivers (TSX: RIV) (OTC: CNPOF) has set a filing date for its Q2 2021 financial results. The company plans to release its Q2 FY 2021 financial report on Nov. 9, 2020, before the market…
-
MissionIRNewsBreaks – Cybin Corp. Paves Path to Profitability with Health-Care Veteran at the Helm
Cybin Corp., a Canada-based, life-science company advancing psychedelic pharmaceuticals, recently announced the appointment of Doug Drysdale as its CEO (https://ibn.fm/UTTdr). Drysdale, named an Ernst and Young Entrepreneur of the Year in 2012, brings more than…
-
MissionIRNewsBreaks – Why Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Is ‘One to Watch’
Processa Pharmaceuticals (NASDAQ: PCSA) is a clinical-stage biopharmaceutical company focused on the development of drug products for patients with high unmet medical need conditions or no alternative treatment options. A recent article discussing the company…
-
CYBIN Corp. Set to Benefit from Growing Research, Interest in Psychedelics
Backed by an anonymous donor, Berkeley launches a center for psychedelic science and public education Berkley follows examples of other notable universities such as Johns Hopkins in Maryland, Imperial College in London, and Canadian Centre…
Search Articles
Latest Articles
- MissionIRNewsBreaks – Clene Inc. (NASDAQ: CLNN) Advances Toward NDA Submission for ALS Therapy
- OptimumBank Holdings Inc. (NYSE American: OPHC) Reports Higher Q2 Earnings as Deposits and Margins Expand
- Vision Marine Technologies Inc. (NASDAQ: VMAR) Strengthens Electric Watercraft Position with Seabob Partnership
- Soligenix Inc. (NASDAQ: SNGX) Showcases Expanding Rare Disease, Public Health Pipeline in Latest Corporate Presentation
- MissionIRNewsBreaks – Newton Golf Company Inc. (NASDAQ: NWTG) Named Official Partner of World Long Drive 2025 Season